WRBY
Company Description
Warby Parker Inc. operates as a purveyor of optical products and related services. Their extensive product line includes prescription eyeglasses, sunglasses, and contact lenses, alongside specialized lens options such as light-responsive (photochromic) and blue-light-filtering variants. Customers can also acquire a variety of accessories, including protective cases, lens care kits equipped with anti-fog spray, pouches, and individual anti-fog lens sprays. Beyond product sales, Warby Parker facilitates direct-to-consumer eye examinations and vision assessments. These services are accessible through their physical retail locations, online platform, and dedicated mobile applications. By May 16, 2022, the company had established a network of 160 brick-and-mortar stores across the United States and Canada. Originally incorporated as JAND, Inc. in 2009, the organization officially rebranded to Warby Parker Inc. in June 2021. Its corporate headquarters are situated in New York, New York.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 871.90M | 771.32M | 669.76M | 598.11M | 540.80M | 393.72M | 370.46M |
| Net Income | 1.64M | (20.39M) | (63.20M) | (110.39M) | (144.27M) | (55.92M) | 0 |
| EPS | 0.01 | -0.17 | -0.54 | -0.96 | -1.39 | -0.50 | -0.52 |
| Free Cash Flow | 43.74M | 34.71M | 7.32M | (49.81M) | (80.51M) | 12.69M | (11.24M) |
| FCF / Share | 0.36 | 0.29 | 0.06 | -0.43 | -0.71 | 0.11 | -0.10 |
| Operating CF | 110.78M | 98.74M | 60.99M | 10.37M | (31.99M) | 32.76M | 21.39M |
| Total Assets | 720.92M | 676.49M | 580.31M | 568.71M | 440.65M | 444.75M | 175.86M |
| Total Debt | 233.15M | 225.35M | 174.46M | 173.38M | 0 | 0 | 0 |
| Cash & Equiv | 286.36M | 254.16M | 216.89M | 208.59M | 256.42M | 314.08M | 55.42M |
| Book Value | 367.73M | 340.07M | 301.79M | 286.65M | 286.00M | 308.41M | 73.40M |
| Return on Equity | 0.00 | -0.06 | -0.21 | -0.39 | -0.50 | -0.18 | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 242.45M | 211.97M | 221.68M | 214.47M | 223.78M | 190.64M | 192.45M | 188.22M | 200.00M | 161.85M | 169.85M | 166.09M |
| Net Income | 3.18M | (5.95M) | 5.87M | (1.75M) | 3.47M | (6.88M) | (4.07M) | (6.76M) | (2.68M) | (19.05M) | (17.41M) | (15.93M) |
| EPS | 0.03 | -0.05 | 0.05 | -0.01 | 0.03 | -0.06 | -0.03 | -0.06 | -0.02 | -0.16 | -0.15 | -0.14 |
| Free Cash Flow | 8.37M | 8.13M | (1.52M) | 23.91M | 13.21M | 2.19M | 13.06M | 13.97M | 5.49M | 92,000 | 4.44M | 6.53M |
| FCF / Share | 0.07 | 0.07 | -0.01 | 0.20 | 0.11 | 0.02 | 0.11 | 0.12 | 0.05 | 0.00 | 0.04 | 0.06 |
| Operating CF | 24.51M | 23.25M | 17.97M | 40.20M | 29.36M | 19.91M | 27.28M | 31.62M | 19.93M | 13.66M | 19.93M | 18.75M |
| Total Assets | 736.41M | 720.92M | 706.92M | 701.90M | 682.75M | 676.49M | 637.99M | 618.21M | 592.89M | 580.31M | 574.88M | 561.71M |
| Total Debt | 237.63M | 233.15M | 232.53M | 228.38M | 223.66M | 225.35M | 196.17M | 192.25M | 181.45M | 174.46M | 170.18M | 170.35M |
| Cash & Equiv | 288.25M | 286.36M | 280.36M | 286.38M | 265.07M | 254.16M | 251.03M | 237.96M | 220.38M | 216.89M | 215.97M | 212.66M |
| Book Value | 375.81M | 367.73M | 369.62M | 361.45M | 354.09M | 340.07M | 336.75M | 329.39M | 316.19M | 301.79M | 304.61M | 302.06M |
| Return on Equity | 0.01 | -0.02 | 0.02 | -0.00 | 0.01 | -0.02 | -0.01 | -0.02 | -0.01 | -0.06 | -0.06 | -0.05 |